163 related articles for article (PubMed ID: 33627833)
1. Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.
Uchino K; Vu Quang L; Mizuno S; Horio T; Yamamoto H; Hanamura I; Kodera Y; Luis Espinoza J; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Doki N; Miyamura K; Mori T; Morishita E; Nakao S; Takami A
Genes Immun; 2021 May; 22(1):35-43. PubMed ID: 33627833
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor genetic variations in bone marrow transplantation.
Uchino K; Mizuno S; Sato-Otsubo A; Nannya Y; Mizutani M; Horio T; Hanamura I; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Ogawa S; Takami A
Oncotarget; 2017 Jul; 8(28):45670-45686. PubMed ID: 28484092
[TBL] [Abstract][Full Text] [Related]
3. Recipient
Nomoto H; Takami A; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Morishita E
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626079
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.
Uchino K; Mizuno S; Mizutani M; Horio T; Hanamura I; Espinoza JL; Matsuo K; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori TM; Takami A;
Transpl Immunol; 2016 Sep; 38():60-6. PubMed ID: 27369862
[TBL] [Abstract][Full Text] [Related]
5. Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignancies.
Espinoza JL; Takami A; Onizuka M; Morishima Y; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
Biol Blood Marrow Transplant; 2013 Feb; 19(2):240-6. PubMed ID: 23025987
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.
Espinoza LJ; Takami A; Nakata K; Yamada K; Onizuka M; Kawase T; Sao H; Akiyama H; Miyamura K; Okamoto S; Inoue M; Fukuda T; Morishima Y; Kodera Y; Nakao S;
PLoS One; 2011; 6(8):e23827. PubMed ID: 21886827
[TBL] [Abstract][Full Text] [Related]
7. Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.
Horio T; Morishita E; Mizuno S; Uchino K; Hanamura I; Espinoza JL; Morishima Y; Kodera Y; Onizuka M; Kashiwase K; Fukuda T; Doki N; Miyamura K; Mori T; Nakao S; Takami A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32059452
[TBL] [Abstract][Full Text] [Related]
8. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
[TBL] [Abstract][Full Text] [Related]
9. The Chaperone UNC93B1 Regulates Toll-like Receptor Stability Independently of Endosomal TLR Transport.
Pelka K; Bertheloot D; Reimer E; Phulphagar K; Schmidt SV; Christ A; Stahl R; Watson N; Miyake K; Hacohen N; Haas A; Brinkmann MM; Marshak-Rothstein A; Meissner F; Latz E
Immunity; 2018 May; 48(5):911-922.e7. PubMed ID: 29768176
[TBL] [Abstract][Full Text] [Related]
10. NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies.
Espinoza JL; Takami A; Onizuka M; Sao H; Akiyama H; Miyamura K; Okamoto S; Inoue M; Kanda Y; Ohtake S; Fukuda T; Morishima Y; Kodera Y; Nakao S;
Haematologica; 2009 Oct; 94(10):1427-34. PubMed ID: 19794085
[TBL] [Abstract][Full Text] [Related]
11. Role of Genetic Polymorphism of ALDH2 in Hematopoietic Stem Cell Transplantation.
Ugai T; Kanda Y; Morishima Y; Matsuo K
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1374-1380. PubMed ID: 28389253
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structures of Toll-like receptors in complex with UNC93B1.
Ishida H; Asami J; Zhang Z; Nishizawa T; Shigematsu H; Ohto U; Shimizu T
Nat Struct Mol Biol; 2021 Feb; 28(2):173-180. PubMed ID: 33432245
[TBL] [Abstract][Full Text] [Related]
13. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
14. The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.
Horio T; Mizuno S; Uchino K; Mizutani M; Hanamura I; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Takami A
Transpl Immunol; 2017 Jun; 42():34-39. PubMed ID: 28487238
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
Xiao H; Luo Y; Lai X; Fu S; Shi J; Tan Y; He J; Xie W; Zheng W; Wang LM; Zhang L; Liu L; Ye X; Yu X; Cai Z; Lin M; Huang H
Haematologica; 2012 Dec; 97(12):1804-12. PubMed ID: 22733023
[TBL] [Abstract][Full Text] [Related]
16. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
17. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
[TBL] [Abstract][Full Text] [Related]
18. Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation.
Leis J; Porter DL
Leuk Lymphoma; 2002 Jan; 43(1):9-17. PubMed ID: 11908741
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies.
Schwenk L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Apr; 148(4):985-991. PubMed ID: 34152493
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.
Inoue N; Katsumata Y; Watanabe M; Ishido N; Manabe Y; Watanabe A; Masutani R; Hidaka Y; Iwatani Y
Autoimmunity; 2017 May; 50(3):182-191. PubMed ID: 28013570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
